InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
OVA peptides | Contributions of direct versus indirect mechanisms for regulatory dendritic c... | 2018 | PLoS One. | Ma Y. et al. | DOI: 10.1371/journal.pone.0190414 |
Primocin® | PRDM14 is expressed in germ cell tumors with constitutive overexpression alte... | 2018 | Stem Cell Res. | Gell J.J. et al. | DOI: 10.1016/j.scr.2017.12.016 |
Fungin™ - Antifungal Reagent | Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome ... | 2018 | Nat Protoc. | Roper J. et al. | DOI: 10.1038/nprot.2017.136 |
Normocin® - Antimicrobial Reagent | Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome ... | 2018 | Nat Protoc. | Roper J. et al. | DOI: 10.1038/nprot.2017.136 |
QUANTI-Blue™ | Neonatal selection by Toll-like receptor 5 influences long-term gut microbiot... | 2018 | Nature. | Fulde M. et al. | DOI: 10.1038/s41586-018-0395-5 |
FLA-ST (Standard or Ultrapure) | Neonatal selection by Toll-like receptor 5 influences long-term gut microbiot... | 2018 | Nature. | Fulde M. et al. | DOI: 10.1038/s41586-018-0395-5 |
Mouse TLR5 Reporter HEK293 Cells (NF-κB) | Neonatal selection by Toll-like receptor 5 influences long-term gut microbiot... | 2018 | Nature. | Fulde M. et al. | DOI: 10.1038/s41586-018-0395-5 |
ODN 2088 | Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth a... | 2018 | Diabetologia. | Liu M. et al. | DOI: 10.1007/s00125-018-4705-0 |
ATP | Triggers of NLRC4 and AIM2 inflammasomes induce porcine IL-1β secretion. | 2018 | Vet Res Commun. | Ahn H. et al. | DOI: 10.1007/s11259-018-9729-x |
Human TLR7 Reporter HEK293 Cells (NF-κB) | Small-Molecule TLR8 Antagonists via Structure-Based Rational Design. | 2018 | Cell Chem Biol. | Hu Z. et al. | DOI: 10.1016/j.chembiol.2018.07.004 |
Human TLR9 Reporter HEK293 Cells (NF-κB) | Small-Molecule TLR8 Antagonists via Structure-Based Rational Design. | 2018 | Cell Chem Biol. | Hu Z. et al. | DOI: 10.1016/j.chembiol.2018.07.004 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | Small-Molecule TLR8 Antagonists via Structure-Based Rational Design. | 2018 | Cell Chem Biol. | Hu Z. et al. | DOI: 10.1016/j.chembiol.2018.07.004 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Small-Molecule TLR8 Antagonists via Structure-Based Rational Design. | 2018 | Cell Chem Biol. | Hu Z. et al. | DOI: 10.1016/j.chembiol.2018.07.004 |
HEK-Blue™ Null1 Cells | Small-Molecule TLR8 Antagonists via Structure-Based Rational Design. | 2018 | Cell Chem Biol. | Hu Z. et al. | DOI: 10.1016/j.chembiol.2018.07.004 |
Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), amel... | 2018 | PLoS One. | Blank M. et al. | DOI: 10.1371/journal.pone.0200615 |
RAW-Blue™ Cells | Cationic lipids as one-component vaccine adjuvants: A promising alternative t... | 2018 | J Control Release. | Pizzuto M. et al. | DOI: 10.1016/j.jconrel.2018.08.020 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its B... | 2018 | Front Immunol. | Lembo-Fazio L. et al. | DOI: 10.3389/fimmu.2018.01888 |
LPS-B5 (LPS from E. coli O55:B5) | Interleukin 4 is inactivated via selective disulfide-bond reduction by extrac... | 2018 | PNAS | Plugis N.M. et al. | DOI: 10.1073/pnas.1805288115 |
ATP | An ethnobotanical survey and inhibitory effects on NLRP3 inflammasomes/Caspas... | 2018 | J Ethnopharmacol. | Tomani J.C.D. et al. | DOI: 10.1016/j.jep.2018.08.016 |
MPLA Synthetic VacciGrade™ | Site-directed polymer-drug complexes for inflammatory bowel diseases (IBD): F... | 2018 | J Control Release. | Kesharwani S.S. et al. | DOI: 10.1016/j.jconrel.2018.08.004 |